San Diego Business Journal

Recent Stories

Executive Q&A: Aaron Hall, Borrego Solar

Aaron Hall, Borrego Solar

Before he became a 21-year-old CEO of one of the largest solar companies in San Diego, Aaron Hall had already flexed his entrepreneurial skills — starting on the playground.

Pull of Biotechs Draws a GSK Satellite Office Into S.D. Space

Pharmaceutical giant GlaxoSmithKline has officially joined the roster of major drug companies with offices in San Diego. Earlier this month, the company opened a local site to manage its research and development partnerships on the West Coast.

Orange Is New Green: Alternative Arrives For Pharmacy Bottles

MEDICINE: Company Targets Big Market With New Container

Each year, the medical industry dispenses billions of prescriptions, most of them in those ubiquitous orange plastic bottles, many of which find their way into landfills.

Tease photo

Steven Chen Joins Avelas Biosciences as VP of Clinical Affairs

Avelas Biosciences Inc., a cancer diagnostic company focused on improving cancer surgeries, announced Thursday that it has started a Phase 1b study of its lead fluorescent cancer illuminator, AVB-620, in women with primary non-recurrent breast cancer.

Receptos Reports Positive Results For Ulcerative Colitis Drug

Receptos Inc. stock was up 5 percent Thursday morning following the company’s announcement regarding its lead product candidate ozanimod.

UC Irvine to Conduct Clinical Trial of Aethlon Device

Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that it has entered into a clinical trial agreement with the University of California, Irvine.

Ichor, Janssen Partner to Develop DNA-Based Vaccines

San Diego-based Ichor Medical Systems said Monday that it has partnered with Janssen Pharmaceuticals to develop DNA-based vaccines. The privately held biotech can earn up to $85 million under the contract, along with royalties on any product sales.

Cerner, Qualcomm Life Bring Health Monitoring into Home

Cerner Corp. and Qualcomm Life Inc., a subsidiary of Qualcomm Inc., announced Monday an agreement to extend Cerner's medical device connectivity capabilities beyond the hospital to the home.

Neothetics Begins Phase 3 Trials of Weight-Loss Drug

Neothetics Inc., a maker of cosmetic pharmaceutical therapies, announced Monday that it has initiated two Phase 3 trials for its drug candidate meant to reduce “abdominal bulging” in non-obese patients.

Tease photo

Fitness App Aims for Strength in Numbers

TECH: It Offers Access to Network of Studios, Classes

The Internet’s middleman economy continues to shake up brick-and-mortar businesses in every industry.

More stories